Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects
- 3 November 2010
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 303 (5) , 317-325
Abstract
The aim of the study was to evaluate the prevalence of pheochromocytoma (PHEO) in patients with neurofibromatosis type 1 (NF1), and to analyze the behavior of some anthropometric and cardiovascular parameters. In 48 consecutive NF1 patients, urinary metanephrines and vanillylmandelic acid excretion were assessed. The body mass index (BMI), waist circumference (WC), ambulatory blood pressure monitoring (ABPM), echocardiography and ultrasound carotid arterial wall evaluation were performed. In NF1 patients, 11 (29.3%) had arterial hypertension, 7 (14.6%) had a PHEO. Four (57%) NF1 patients with PHEO were symptomatic at the diagnosis. In PHEO-NF1 patients, we revealed a lower BMI and WC values with respect to NF1 patients without PHEO and normal subjects (NSs) (p < 0.05), respectively. The nocturnal non-dipping pattern at the ABPM was present in 40.4% of NF1 patients, and in particular this phenomenon was present in PHEO-NF1 patients (71.4%). Left ventricular mass index and intima media thickness were significantly higher in NF1 patients as compared to NS (p < 0.05), particularly in NF1-PHEO patients (p < 0.05). In conclusions, these findings revealed high prevalence of PHEO in NF1 patients and suggest that, in addition to blood pressure, humoral factors (increased sympathetic activity or neurofibromin), influence the pathogenesis of remodeling of cardiovascular system.Keywords
This publication has 34 references indexed in Scilit:
- Cardiomyocyte-Specific Loss of Neurofibromin Promotes Cardiac Hypertrophy and DysfunctionCirculation Research, 2009
- Coincidence of Neurofibromatosis Type 1 and Multiple Endocrine Neoplasia Type 2The Endocrinologist, 2008
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Diagnosis and Localization of PheochromocytomaHypertension, 2004
- Pheochromocytoma: State-of-the-Art and Future ProspectsEndocrine Reviews, 2003
- Molecular Characterization and Gene Content of Breakpoint Boundaries in Patients with Neurofibromatosis Type 1 with 17q11.2 MicrodeletionsThe American Journal of Human Genetics, 2001
- Epidemiology of neurofibromatosis type 1American Journal of Medical Genetics, 1999
- NeurofibromatosisCurrent Opinion in Pediatrics, 1997
- The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytomaWorld Journal of Surgery, 1992
- Echocardiographic findings in pheochromocytomaThe American Journal of Cardiology, 1986